Search research articles
Contact Us
Filters
Showing results (191-200 of 205) with videos related to
Page
of 21
Sort By:
European Urology Oncology
|
December 21, 2024
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
Tanya Jindal, Cindy Jiang, Omar Alhalabi, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer
David J McConkey, Brian C Baumann, Stephanie Cooper Greenberg, et al.
European Urology Open Science
|
December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Karen A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 16, 2020
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline
Edouard J Trabulsi, R Bryan Rumble, Hossein Jadvar, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
March 4, 2025
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer<sup></sup>
Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, et al.
Cancer
|
May 5, 2021
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer
Daniel J George, Susan Halabi, Elisabeth I Heath, et al.
Cancer
|
December 9, 2021
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
Vadim S Koshkin, Nicholas Henderson, Marihella James, et al.
The Oncologist
|
October 7, 2025
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study
Cindy Y Jiang, Hyunsoo Hwang, Ilana Y Epstein, et al.
European Urology
|
October 12, 2016
Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)
Andrea Necchi, Guru Sonpavde, Salvatore Lo Vullo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2018
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer
Gopa Iyer, Arjun V Balar, Matthew I Milowsky, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 205) with videos related to
Sort By:
Page
of 21
European Urology Oncology
|
December 21, 2024
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
Tanya Jindal, Cindy Jiang, Omar Alhalabi, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer
David J McConkey, Brian C Baumann, Stephanie Cooper Greenberg, et al.
European Urology Open Science
|
December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Karen A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 16, 2020
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline
Edouard J Trabulsi, R Bryan Rumble, Hossein Jadvar, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
March 4, 2025
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer<sup></sup>
Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, et al.
Cancer
|
May 5, 2021
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer
Daniel J George, Susan Halabi, Elisabeth I Heath, et al.
Cancer
|
December 9, 2021
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
Vadim S Koshkin, Nicholas Henderson, Marihella James, et al.
The Oncologist
|
October 7, 2025
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study
Cindy Y Jiang, Hyunsoo Hwang, Ilana Y Epstein, et al.
European Urology
|
October 12, 2016
Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)
Andrea Necchi, Guru Sonpavde, Salvatore Lo Vullo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2018
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer
Gopa Iyer, Arjun V Balar, Matthew I Milowsky, et al.
Page
of 21